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Abstract 
Skeletal muscle depends on its arteriole network to meet metabolic demands during 
physical activity. However, inflammatory mediators can disrupt intercellular communication 
along arterioles, impairing blood flow regulation and thus negatively impact muscle function. 
This project evaluated arteriole responsiveness in the gluteus maximus (a locomotory 
muscle) of C57/BL6 mice in vivo using intravital microscopic techniques. Arterioles were 
demonstrated as functional using specific endothelial and smooth muscle cell specific 
reagents. Inducing inflammation with platelet activating factor (PAF) gave rise to an 
increased degree of arteriolar vasoconstriction as its concentration increased. In contrast, 
vasodilation transitioned to vasoconstriction as histamine concentration increased. However, 
the arteriolar effects of histamine were attenuated during NO inhibition with N^-nitro-L-
arginine methyl ester (L-NAME), illustrating a NO- related mechanism. Therefore, our study 
established the gluteus maximus as a viable candidate for inflammatory studies related to 
locomotion, so that the links between physical activity, inflammation, and microvascular 
health may be investigated. 
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CHAPTER 1: INTRODUCTION 
Chapter 1: Introduction 
1.1 Importance of Skeletal Muscle and the Role of Microcirculation 
Regular physical activity is crucial for maintaining a healthy body. Exercise improves 
the quality of the cardiovascular system, providing protection from many chronic metabolic 
conditions. Another benefit of exercise is an improvement in local blood flow supply, which 
increases in proportion to the metabolic demands of the muscle tissue (Clifford & Hellsten, 
2004). Thus, having a healthy systemic circulation and locomotion abilities to negate the 
onset of cardiovascular disease depends on the local circulation feeding the skeletal muscles. 
Deficiencies in blood flow regulation will result in breakdown of muscle tissue, thus 
increasing susceptibility to a sedentary lifestyle (Payne, 2006). 
The health of skeletal muscles is controlled by their microcirculation. Whereas the 
macrocirculation distributes blood flow globally throughout the body, the microcirculation is 
the critical component for blood flow regulation and homeostasis within individual tissues 
(Trzeciak et al., 2007). A direct exchange of oxygen, nutrients, and waste products take place 
within these tissues (Chierego et ah, 2006). The tissue perfusion and vascular resistance is 
made possible by the high surface area of three types of microvessels: capillaries, arterioles, 
and venules. Capillaries have a diameter of about 5 to 10 \im, whereas arterioles and venules 
have diameters ranging from 10 to 25 |im (Mchedlishvili & Maeda, 2001). Together, these 
vessels are the largest endothelial surface in the mammalian body, encompassing more than 
0.5 km2 of its total surface area (Verdant & De Backer, 2005). The majority of these 
microvessels are contained in skeletal muscle, an organ system that contributes to 40% of 
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total body mass (Payne & Bearden, 2006). Therefore, a large percentage of the body will 
receive cardiovascular benefits if the skeletal muscle perfusion is maintained. 
1.2 Cell Communication within the Arteriolar Network 
In order for skeletal muscle to receive its needed blood supply, molecular signals 
must be communicated through its feeding arterioles via intercellular communication. 
Oxygen and nutrients are fed to the muscle through an intertwined arteriolar network (Figure 
1), which is composed of resistance segments arranged in series and in parallel (Looft-
Wilson et ah, 2004). Through coordinated or conducted vasodilation (CVD), the signal is 
propagated along and between neighbouring branches to maximize the blood delivery of the 
network. 
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Figure 1. Microvasculature of dissected skeletal muscle tissue. Proximal arterioles (1A) 
branch into 2A and 3 A arterioles (in red). The 2A arterioles are of interest in microvascular 
research because they are the major distributing vessels and responsible for nitric oxide (NO) 
contribution (VanTeeffelen et ah, 2005). Note also that arterioles run in parallel to post-
capillary venules (in blue). This can facilitate communication between the components of the 
microcirculation, such as when leukocytes accumulate during inflammation. 
During exercise, the contracting muscle can initiate a signal of vasodilation within the 
arteriolar network to respond to the increase in metabolic demand (Segal & Jacobs, 2001). 
Skeletal muscle can in fact be considered an endocrine organ because contraction stimulates 
the production and release of cytokines that can influence metabolism for both the muscle 
itself and other tissues and organs (Nielsen & Pederson, 2008). A common vasodilating 
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signal produced by the muscle is through the release of acetylcholine (Ach). The Ach 
delivered from the neighbouring muscle fibers triggers a local increase in endothelial cell 
[Ca2+], which activates calcium dependent K+ channels (Kca) (Domeier & Segal, 2007). As 
the endothelial [Ca2+] rises, Kca channels open for K+ to escape and the membrane 
hyperpolarizes, signaling the arteriole to vasodilate (Dora et al., 2003). This process 
continues upstream through the endothelium and the smooth muscle cell layers, relaxing the 
arteriole in less than a second (Payne et al, 2004). The hyperpolarizing signal is spread 
primarily by nitric oxide (NO), prostacyclin (PGI2), and endothelium derived 
hyperpolarization factor (EDHF). These three secondary messengers all travel from the 
endothelium to the vascular smooth muscle to induce relaxation (Matoba & Shimokawa, 
2003). A specific structure of EDHF remains to be clarified, but its hyperpolarization can be 
inhibited by increasing the concentration of extracellular potassium ions or by the presence 
of potassium channel inhibitors (Takano et ah, 2005). 
An increase in [Ca2+] may be the initiator of vasodilation locally, but endothelial 
[Ca2+] did not increase at distances of 500 and 1000 \im upstream from the site of initiation 
(Dora et ah, 2003). It is more difficult for Ca2+ to travel along the arteriole because the 
arteriolar response depends on the electrical resistance of the pathway the CVD travels 
(Kurjiaka, 2004). To overcome these electromechanical obstacles, the endothelium must rely 
on other molecular messengers. Whereas Ca2+ travels slowly along the endothelium (-111 
um/ second), the NO and PGI2 activated by Ca can transmit faster (~1 mm/ second) 
(Domeier & Segal, 2007). Secondary messengers can therefore carry the CVD signal more 
quickly and efficiently. The observation of vasodilation upstream of stimulation (de Wit, 
2004) also illustrates that vasoactive signals are not merely flow-mediated and must travel 
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between cells of the arteriole against the current of blood flow. Thus, having strong cell 
communication within the arteriole will facilitate the spread of vasodilatory signals. 
1.3 Intravascular Signaling and Gap Junctions 
The three major intercellular junctions responsible for vascular continuity are tight 
junctions, adherens junctions, and gap junctions. Tight junctions prevent vascular leakage 
between cells, adherens junctions link the cytoskeleton, and gap junctions allow intercellular 
communications. Therefore, gap junctions are essential for allowing the transmission of 
vasoactive messages. These junctions consist of connexin subunits assembled into hexameric 
channels, which mediate the direct exchange of ions and small molecules (second 
messengers, metabolites, linear peptides, mRNA) between the cells (Chanson & Kwak, 
2007). To date, 21 connexin subunits (Cx's) have been described (Tran & Welsh, 2009). In 
general, Cx37 and Cx40 subunits are found predominantly in endothelial gap junctions and 
Cx43 and Cx45 subunits are found in smooth muscle gap junctions (Figueroa et ah, 2003). 
These gap junctions are present in both endothelial and smooth muscle cells of the arteriole, 
but connexin assembly can differ (de Wit, 2004). Variation in connexin assembly has been 
shown to correspond to arteriole function. For example, Cx40 deficient mice were found to 
have a slower spread of vasodilation in skeletal muscle arterioles, as well as a higher blood 
pressure (de Wit et ah, 2000). Thus, there is potential for diversity of cell communication 
within the arteriole. 
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Of the two cell layers within the arteriole, it is known that the endothelium is the 
main type driving the CVD. This is because larger levels of connexin expression were found 
in endothelial cells than in smooth muscle cells of skeletal muscle (Looft-Wilson et ah, 
2004). The smooth muscle layer is also more heterogeneously coupled by gap junctions that 
are small and rare (Rummery & Hill, 2004). Myoendothelial gap junctions have been found 
between the two microvascular layers, but they are smaller and less numerous than the 
homocellular gap junctions (Griffith, 2004). The importance of each vascular layer has also 
been tested using selective damage. One method uses light-dye treatment to photodamage 
abluminal (smooth muscle) or luminal (endothelium) regions before the CVD induction. 
When vasodilation was induced in the hamster retractor muscle after this damage, conduction 
was impaired along the damaged segment; selective smooth muscle damage had no effect on 
conduction past the damaged site (Emerson & Segal, 2000). Therefore, the strength of a 
vasodilatory wave depends primarily on the cell communication within the endothelium. 
1.4 The Effect of Inflammation on Skeletal Muscle Health 
One of the potential promoters of skeletal muscle dysfunction is inflammation (Visser 
et ah, 2002). Inflammation can directly impact both the skeletal muscle and its feeding 
microcirculation, particularly in an aging population. An increased rate in muscle atrophy 
found in aging individuals is associated with the presence of chronic low-grade inflammation 
(Hsu et al., 2009). For instance, higher plasma concentrations of IL-6 and TNF-a 
(inflammatory mediators) are associated with lower muscle mass and strength in well-
functioning older men and women (Pedersen et al., 2003; Visser et ah, 2002). Chronic low-
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grade inflammation is characterized by a two- to four-fold elevation in circulating levels of 
inflammatory mediators, as well as minor increases in counts of neutrophils and natural killer 
cells (Bruunsgaard, 2005). In addition, an increased number of mast cells, a source of 
inflammatory mediators, are found in aging individuals (Kruger & Lagunoff, 1981). The 
inflammatory environment can also give rise to endothelial dysfunction, interfering with the 
ability of arterioles to dilate. For example, endothelium-dependent vasodilation was found to 
be reduced in arterioles from skeletal muscles of aged animals (Muller-Delp, 2002). Reduced 
blood flow diminishes the arteriole's ability to meet muscle's metabolic demands, 
consequently limiting the ability of older adults to perform functional tasks. 
Regardless of age, exercise helps lower the inflammatory state within muscles. For 
instance, inflammatory mediators obtained from muscle biopsies were reduced by 50% in the 
frail, obese elderly after exercise, whereas weight loss had no effect (Lambert et ah, 2008). 
However, muscle mass in the highly active elderly is still lower than that of younger 
individuals with sedentary lifestyles (Klitgaard, 1990). This discrepancy is due to sarcopenia, 
also known as age-related muscle wasting. In addition to a loss of skeletal muscle mass, this 
disease is characterized by a gradual decline in muscle function, such as a general slowing of 
contraction and relaxation (Ryall et ah, 2008). However, future damage by inflammatory 
mediators may be minimized with exercise training, which decreases levels of circulating 
inflammatory monocytes (Timmerman et ah, 2008). Exercise is clearly beneficial for the 
elderly (Lambert et al., 2008), but in a limited manner when there is less functional skeletal 
muscle to utilize. The increased metabolic demand put on the remaining muscle tissue makes 
microcirculation perfusion even more crucial. 
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A prevailing inflammatory state is not necessarily restricted to the elderly. There are 
numerous conditions that create a chronic inflammatory state within the microvasculature of 
skeletal muscle. For instance, the inflammation caused by chronic obstructive pulmonary 
disease is linked to increased muscle wasting (Degens & Alway, 2005). Furthermore, weight 
gain is associated with a higher expression of inflammatory mediators in human skeletal 
muscle, as indicated by the similar inflammatory profiles of overweight middle-aged men 
and the elderly (de la Maza et al., 2006). Even a single high fat meal reduced brachial artery 
endothelium-dependent vasodilation for up to four hours in healthy, normocholesterolemic 
volunteers (Plotnick et al., 1997). An increase in weight is also tied to microvascular 
complications in animals. For example, a diet high in fat impaired the endothelium-
dependent dilations of skeletal muscle arterioles in rats, due to the increased presence of 
oxidative stress (Erdei et al. 2006). Therefore, an individual's age can be considered a 
relative term, as the amount of circulating inflammatory mediators and lifestyle affects the 
physiology of the microcirculation. 
A low-grade chronic inflammatory state will cause microvascular dysfunction, but so 
will a severe, acute inflammatory state. The onset of sepsis is an excellent example of this 
other end of the inflammatory spectrum. During temporary states of acute inflammation, the 
body's defenses can usually clear minor infections while causing minimal damage to nearby 
tissues (Bucci et ah, 2005). During sepsis, the immune system becomes hyper-inflammatory 
as it attempts to destroy any challenging pathogens, upregulating inflammatory mediators 
and reactive oxygen species (ROS) (Rudiger et al., 2008). ROS are proinflammatory 
mediators that are capable of activating matrix degrading proteins (MMPs), which will 
induce apoptosis of nearby cells (Xiong et al., 2008). Even though this aggressive reaction 
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will destroy pathogens, the body's own muscle and vascular cells can become collateral 
damage. Thus, sepsis may cause muscular atrophy through direct and indirect methods. 
If not reversed, systemic inflammation can lead to multiple organ failure (Sakr et al, 
2004). The current challenge in treating this type of inflammation is illustrated by the impact 
of septic shock in hospitals. This condition remains the predominant killer throughout 
intensive care units, with high mortality rates (Groeneveld et al., 2008). For instance, Sakr et 
al. (2004) observed that among 49 intensive care unit patients suffering from septic shock, 
only 26 overcame their condition. Doctors respond to this condition by restoring the blood 
pressure and cardiac output (i.e. macrocirculation) in these patients, but septic shock was not 
overcome without improved microvessel perfusion (Sakr et al, 2004; Trzeciak et al, 2008). 
A healthy macrocirculation does not necessarily translate to a healthy microcirculation. 
Another validation of this concept is how patients can have normal coronary angiograms, yet 
also an abnormal arteriolar response to sympathetic stimulation because of prevailing 
systemic microinflammation (Schindler et al., 2004). If the impact of the inflammation on the 
microcirculation can be better understood, more effective therapies can be designed that 
utilize the complete cardiovascular tree. Furthermore, mortality from systemic inflammation 
will be decreased by repairing the microcirculation of the body's largest organ: skeletal 
muscle. 
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1.5 Inflammation and Endothelial Integrity 
The endothelium is a semi-permeable barrier that regulates the transport of fluids and 
solutes into and out of the blood. This barrier is held together by cell adhesion structures-
distinct trans-membrane proteins that assemble into arrays, strands, or focal contacts 
(Segretain & Falk, 2004). Vascular permeability in the microcirculation is essential for 
maintaining tissue perfusion. However, vascular permeability is also a characteristic of many 
disease states when permeability increases beyond regular limits, such as during 
inflammation (Nagy et ah, 2008). Within normal physiological parameters, permeability is 
tightly regulated and reversible. The endothelial cells will display vasodilator, anti-coagulant 
and anti-adhesive properties (Crimi et ah, 2007). Yet, during inflammation the disruption of 
the vascular barrier often results in the recruitment of platelets and leukocytes to the site of 
the leak (Weis, 2008). The endothelial activation during inflammation will consequently 
allow molecules to cross and infiltrate the intravascular space and threaten endothelial 
integrity (Payne, 2006). This loosened adhesion could be through inflammatory mediators 
disrupting tight junctions, gap junctions, and adherens junctions between endothelial cells 
(Payne et ah, 2004). If the disruption of endothelial integrity is considered within the realm 
of vasomotor signal conduction, it becomes apparent that an inflammatory state will break 
down cell communication. The induced vascular hyperpermeability has been found to impair 
CVD because the endothelial gaps allow ions and proteins to escape (Nagy et ah, 2008). 
Consequently, vasoactive signals will be more difficult to conduct through the uncoupled 
pathway to meet the demand of the skeletal muscle tissue. 
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It is important to note that disruption of vascular integrity has already been observed 
in capillaries and post-capillary venules. For example, electron microscopy has shown that 
the addition of histamine to skeletal muscle microcirculation causes partial disconnection of 
the intercellular junctions between endothelial cells of venules (Majno & Palade, 1961). Yet, 
little research has focused on the direct effects of inflammation on the intercellular 
communication of the arterioles. It is also just as likely that the cytoskeleton between 
arteriolar subunits is becoming loosened, as proposed by Payne (2006). When researched in 
vitro, the application of inflammatory mediators inhibited gap junctional intercellular 
communication between cultured human endothelial and smooth muscle cells (Hu & 
Cotgreave, 1997). Also, permeability to macromolecules in arterioles was found to be lower 
than venules under noninflammatory conditions (Sarelius et ah, 2005). Inflammatory 
mediators may also affect gap junction expression by decoupling connexin coregulation, 
leading to altered structures and disturbed vascular heterocellular communication (Isakson et 
ah, 2006). Bolon et al. (2008) found that the induction of sepsis has disrupted cell 
communication within the endothelium of mouse skeletal muscle by phosphorylating Cx40. 
The decreased endothelial cell coupling during inflammation can contribute to endothelial 
dysfunction as well as alter vasomotor responses (Simon et al., 2004). Even if vasodilation is 
still possible at a local site, the supply to the rest of the muscle will be minimal without 
proper cell communication. Further research is required to clarify the inflammatory 
mechanisms that interfere with blood flow to skeletal muscle. 
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1.6 Disruption of Nitric Oxide Balance 
One of the key secondary messengers studied in microvascular health research is 
nitric oxide (NO). This is a potent vasodilator produced by three different nitric oxide 
synthases (NOS) within mammalian tissue. The NO generated by the neuronal NOS (nNOS) 
and endothelial NOS (eNOS) isozymes has beneficial effects such as vasodilation, inhibition 
of platelet aggregation and leukocyte adhesion to the endothelium (Crimi et al., 2007). Thus, 
both the endothelium and neurons are potential sources of NO within skeletal muscle tissue 
that can be used during contraction (Clifford & Hellsten, 2004). The eNOS and nNOS 
isoenzymes generally produce low, physiological levels of NO and require an increase in 
intracellular calcium to stimulate activity (Gocan et al., 2000). A calcium requirement 
ensures vasodilatory regulation. Gap junction conductivity can also be modulated through 
NO acting on connexins within the arteriole (Rodenwalt et ah, 2007). 
The NO production pathway is a key mechanism for inflammatory agents to inhibit 
CVD when activated to an excess (Payne et al., 2004). Consequently, active skeletal muscles 
will receive a lower blood supply. For instance, the inflammatory overdrive present in sepsis 
causes so much NO overproduction in rats that after five hours, their skeletal muscle oxygen 
consumption dropped by 50% (Bateman et al., 2008). The large surplus of NO can also react 
with any superoxide anions to produce toxic compounds (Toda et al., 2008). For example, 
O2" (a ROS) will combine with NO to generate peroxynitrite (ONOO), causing DNA strand 
breakage within cells (Cinel & Opal, 2009). High levels of NO are also seen within the 
skeletal muscle of aging mice during a chronic state of low-grade inflammation (Bearden, 
12 
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2007). Therefore, the health of both skeletal muscle and its embedded microvasculature will 
be threatened if NO is not regulated. 
Production of NO can become excessive when inducible nitric oxide synthase 
(iNOS), the third isozyme, becomes activated by inflammatory stimuli. Whereas eNOS and 
nNOS generate low levels of NO, iNOS activation produces a larger and more persistent 
concentration. This can lead to problems such as hypotension, negative inotropic effect, pro-
oxidant properties, apoptosis, mediation of the effects of cytokines, and cytotoxic innate 
immunity (Crimi et al, 2007). Overproduction of NO can also lead to a dramatic decrease in 
red blood cell (RBC) deformability, which can lead to random blockage of the microvascular 
beds and reduced blood flow (Bateman et al, 2001). Thus, this imbalance will induce self-
destructive signals within the body. Also, the presence of iNOS in both myocytes and 
endothelial cells (Cengel & Sahinarslan, 2006) can make the enzyme very influential on 
skeletal muscle microcirculation. Furthermore, this isoform is calcium independent, so it can 
respond to various other molecular signals outside of the skeletal muscle to produced high 
levels of NO (Gocan et ah, 2000). An overview of NO production is illustrated in Figure 2. 
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Figure 2. The NO production pathway. Vasodilators (VD) bind to endothelial receptors to 
stimulate NO synthesis via a calcium dependent mechanism. The nNOS pathway is also 
calcium dependent within neurons. In contrast, inflammatory mediators (IM) stimulate NO 
synthesis in a calcium independent manner. The synthesized NO then travels to the smooth 
muscle layer to stimulate cyclic guanosine monophosphate (cGMP) synthesis, consequently 
promoting relaxation in the arteriole. Note that NO is produced by the NOS isozymes in 
other cell types as well. 
Although eNOS and nNOS have traditionally been attributed to healthy NO 
production, there have been documented exceptions. For instance, upregulated nNOS has 
also been shown to impair vasodilative responses in skeletal muscle (Gocan et al., 2000) and 
eNOS has been shown to be upregulated during sepsis (McKinnon et al., 2006). Thus, all 
three have the potential to impair cell communication with the appropriate trigger from 
inflammatory mediators. Regardless of the source, elevated levels of NO are hypothesized to 
compromise intercellular coupling during inflammation (McKinnon et al., 2006). The key to 
arteriolar health is keeping NO levels down to baseline levels so that the endothelial function 
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may be maintained. Conducted vasodilation may still occur without NO release from the 
endothelium (Payne et ah, 2004), but it could be much weaker from having to rely on the 
PGI2 and EDHF messengers. Thus, microvascular efficiency in the skeletal muscle will be 
greater if NO levels are regulated. 
1.7 Analyzing Microvascular Function with Intravital Microscopy 
Understanding how the microcirculation performs under pathological conditions 
requires observing these processes as they occur. Intravital microscopy (IVM) is the primary 
method used for researching the microcirculation. Using an IVM enables a visualization of 
active microvessels within a tissue in vivo. Tissue is mainly excised from rodents, as their 
small bodies can be rested under the lens of the IVM, allowing a high resolution of the 
microvasculature (Gavins & Chatterjee, 2004). Their thin tissue is excised and pinned onto 
clear silicone to facilitate light penetration through the preparation. Through these techniques 
the individual microvessels can become visible through the lens of the microscope. Once 
tissue is excised from the body, it is immersed in a flowing solution to keep it from drying 
out. Solutions are brought to neutral pH with the necessary salts to maintain physiological 
activity within the microvasculature. In addition, a constant bubbling of CO2/ N2 into all 
flowing solution will act as a buffer, maintaining pH at 7.38-7.44 (Bearden, 2007). Finally, 
all solutions are also immersed in a water bath calibrated to body temperature. Therefore, 
researchers can externalize skeletal muscle from the mouse while still maintaining the 
tissue's physiological environment. 
15 
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In addition to viewing the microcirculation through the microscope eyepiece, the 
IVM also has a video camera attachment. Video-based methods are the method of choice for 
obtaining blood flow measurements in the microvessels because recordings can be saved for 
later off-line processing and analysis (Pittman, 2000). The use of video footage also allows a 
complete recording of time-dependent processes, such as changes in vessel diameter or red 
blood cell velocity through the microvessels (Gavins & Chatterjee, 2004). To enhance 
visibility, fluorescent filters can be fitted to the microscope to measure the signal intensity of 
tagged cells within the tissue, such as detecting microvascular leakage of RBC's with 
fluorescein isothiocyanate-albumin (Baldwin et ah, 1998). Having the IVM camera linked to 
a nearby computer (Figure 3) allows both a qualitative and quantitative measurement of the 
microcirculation in real time. The ability to measure structural and physiological changes so 
effectively makes IVM a crucial tool in inflammation studies. 
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Video camera 
Intravital microscope 
Video screen 
Computerized recording program 
Mouse preparation 
Video calipers 
Figure 3. Intravital microscope apparatus. The microvasculature image viewed through the 
objective lens is fed into a camera attached above. The image is fed into a video screen so 
that vessel diameter can be measured with video calipers. All recordings are stored on a 
linked computer. 
Another benefit of measuring inflammation with IVM is that the same muscle may be 
used as an internal control against future vasoactive reagents. Using the same tissue 
throughout the experiment creates an internal control for treatment, so no sham (euthanized 
controls) and treatment animals need to be compared (Gavins & Chatterjee, 2004). For 
instance, any anti-inflammatory treatments or interventions can be used on the same tissue 
source to visualize effectiveness against pre-treatment characteristics. Thus, this method 
minimizes animal use. 
The major challenge encountered during IVM studies is creating and maintaining a 
physiological environment for the tissue similar to the one inside the mouse before 
experimentation. Thin tissue can easily be seen through the microscope, but it can also be 
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sensitive to post-excision conditions (Kumer et al, 2000). There are many physiological 
variables that must be simultaneously balanced by the researcher during experiments for 
preserving microvascular function and acquiring viable data. For example, if the tissue is not 
handled gently during microsurgery, microvessels will rupture and torn muscle will release 
inflammatory mediators (Gierer et al., 2008). Thus, when performing extended experiments 
on a single sample of tissue, tissue integrity must be monitored at all times. 
In summary, it is clear that a prevailing inflammatory state is detrimental to the 
functionality of the skeletal muscle's embedded microvessels. Cardiovascular deficits have 
been observed in both a clinical setting as well as animal models. In regards to the arteriolar 
network, both chronic low-grade and acute severe inflammation will disrupt its cell 
communication. The presence of inflammatory mediators may disrupt the transmission of 
cellular signals through structural alterations to the endothelial layer (such as 
hyperpermeability or gap junction assembly) or promoting unbalanced production of harmful 
cytokines (such as other mediators, ROS or NO). However, since knowledge regarding the 
impact of inflammation on arterioles is limited, it is important to trial individual mediators in 
the construction of arteriolar inflammatory profiles. Intravital microscopy allows a direct 
visualization of a mouse's skeletal muscle microcirculation in vivo so that these 
inflammatory effects can be recorded. Since inflammation is a predominant force in so many 
diseases today, understanding how it influences the microcirculation will clarify what it takes 
for these conditions to develop. 
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Chapter 2: Research Objectives 
2.1 Mastering the use of IVM to Analyze Skeletal Muscle Microcirculation 
Intravital microscopic techniques are the best method for measuring the 
microcirculation in vivo (Gavins & Chatterjee, 2004). However, since live animals are used, 
many variables need to be simultaneously balanced to produce physiological conditions in 
the externalized tissue and make any obtained results applicable to internal conditions. 
Obtaining viable tissue requires maintaining proper temperature, pH, salt concentration, 
solution flow rate, plane of anesthesia, and surgical efficiency (Kumer et ah, 2000). 
Therefore, experimental procedures must be fine-tuned and followed in a manner to obtain 
data from the IVM that is not only consistent within one experiment, but also agrees with 
results obtained from other animals. Furthermore, each mouse can have its own specific 
physiological challenges, so flexible methods must be designed for obtaining data. In 
addition, animal research protocol must be learned and followed in a manner that is safe for 
each mouse being used, as well as the remaining animals and personnel using the facility. 
Therefore, overcoming the large learning curve of animal physiological research is essential 
before proceeding with data collection on the arterioles of the gluteus maximus. 
2.2 Constructing a Vasoactive Range for Arterioles in a Locomotory muscle 
Constructing a vasoactive profile of the mouse gluteus maximus arteriole network is 
vital measure arteriole reactivity. Two common vasoactive agents used in microcirculatory 
research are acetylcholine (Ach) and phenylephrine (PE). Endothelium-dependent 
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vasodilation is activated when Ach binds muscarinic receptors, whereas PE evokes 
constriction via a-adrenoreceptors on smooth muscle cells (Hungerford et al, 2000). The 
vasodilation induced with Ach and vasoconstriction with PE will enable construction of a 
vasoactive range for the 2A arterioles. The mechanism of action of each reagent also allows 
arteriole reactivity to be broken down into the endothelial and smooth muscle components 
(Bartlett & Segal, 2000). Therefore, the use of each will provide the range of vasomotor 
control within the gluteus maximus. Furthermore, reactive arterioles validate the 
microsurgical techniques being used before inflammation is induced. 
2.3 Observing the Effects of Inflammation on the Arteriolar Aspect of Microcirculation 
More inflammatory research has focused on post-capillary venules rather than 
arterioles because of clear structure changes observed. In particular, gaps between vascular 
units have already been noted in venules after administration of histamine (Majno & Palade, 
1961). This visible increase in microvascular permeability will facilitate leukocyte 
transmigration into the intravascular space (Weis, 2008). To date, no leukocyte 
transmigration across the arteriole wall appears to have been observed (Bailey et al., 2007). 
However, leukocytes could still hypothetically be causing inflammatory effects within the 
arteriole because leukocyte adhesion along the endothelial layer has also been observed in 
arterioles (Bailey et al, 2007; Nolte et al., 2004). It is possible that secreted inflammatory 
mediators could be acting on the arteriole endothelium during this adhesion. The close 
proximity of each component of the microcirculation also makes it possible for inflammatory 
signals to be delivered to arteriolars from neighbouring venules. These signals could also be 
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originating from other cells besides leukocytes, such as platelets and mast cells (Liu & Xia, 
2006) as well as the endothelium itself (Trzeciak et ah, 2008). Therefore, a greater 
understanding of inflammation cannot be achieved without more insight into the arteriolar 
pathophysiology. The second-order (2A) arterioles were examined because these branches 
are the key distributing vessels within the mouse gluteus maximus responsible for regional 
control of blood flow (Bearden et ah, 2007). 
2.4 Observing the Effects of Inflammation on Arterioles in a Locomotory Muscle 
Previous research has studied the effect of inflammation on the arteriole of the mouse 
cremaster muscle. The cremaster is a thin muscular extension of the abdominal wall that 
holds the testes and epididymus in place (Armstrong et ah, 2007a). This makes the cremaster 
a less than ideal candidate for describing conditions linked to physical activity. Furthermore, 
endothelial signaling pathways are specifically adapted to muscle-fiber type and function 
(Muller-Delp et al, 2002). Skeletal muscle tissue is made up of three different types of 
fibers: slow-twitch oxidative fibers, fast-twitch glycolytic fibers, and fast-twitch oxidative/ 
glycolytic fibers (Aaker & Laughlin, 2003). However, skeletal muscles have the ability to 
adjust their fiber composition to adapt to their physiological demands. Their phenotypic 
profiles are affected not only by genetics and innervations/ neuromuscular activity, but also 
by exercise training, hormones, and aging, causing transitions from fast-to-slow or slow-to-
fast fiber types (Jin et ah, 2008). Thus, the different function of each skeletal muscle in the 
body will determine its fiber composition and microvascular function. Since the cremaster 
muscle is located around the testes, the majority of microcirculatory muscle research has 
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been confined to males. Therefore, using the gluteus maximus as a tissue source will remedy 
these problems and open the door for new avenues of research. 
To our knowledge, no previous studies have examined the effect of inflammation or 
the involvement of individual mediators on arterioles of the gluteus maximus in mice. 
Because each mediator may disrupt cell communication to different degrees, obtaining signal 
profiles of each may help in the development of future therapies. Histamine has been used to 
induce inflammation in mouse cremaster arterioles (Payne et ah, 2004), so its use in the 
gluteus maximus will allow a comparison between muscle tissues. This study will also 
examine the impact of platelet activating factor (PAF), another common inflammatory 
mediator. This potent mediator not only induces an inflammatory reaction, but also mediates 
synthesis and release of other mediators to aggravate the degree of inflammation (Chen et ah, 
2008; Liu & Xia, 2006). Consequently, PAF also has a high potential of inducing changes to 
microvascular structures that will affect blood flow regulation. Better understanding these 
common mediators will create a more complete picture of how inflammation affects the 
arteriole. 
2.5. Investigating the Relation of the NO Pathway to Arteriolar Inflammation 
Further understanding how inflammation impacts the skeletal muscle arteriolar 
network requires probing into how diameter changes are mediated. The NO pathway has 
already been confirmed in the cremaster using histamine mediated inflammation. There was 
little effect of this inflammatory mediator on eNOS T mice or when NOS activity was 
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pharmacologically inhibited by nitro-L-arginine (L-NA) (Payne et al., 2004). However, NO 
may not be the only secondary messenger being used to transmit a vasodilatory signal within 
the skeletal muscle arteriolar network. There is the potential for other secondary messengers 
within the endothelium to compensate if the NO pathway is inhibited, such as EDHF or PGI2 
(Hungerford et al., 2000). For example, Spier et al. (2007) found that NO inhibition triggered 
EDHF compensation to transmit CVD signals. Therefore, the predominant pathway being 
utilized by inflammation within a locomotory muscle must be clarified. 
Discovering the pathway used by inflammatory mediators within the gluteus 
maximus is important to see if the effects can be reversed. Changes in arteriolar size could 
potentially be reversed through inhibition of NO production by using of Nw-nitro-L-arginine 
methyl ester (L-NAME), a nonselective NOS inhibitor (Kumer et al, 2000). Thus, NO 
inhibition will help rule out one of the major pathways. The concept of reversibility is 
promising because it shows that treatments may be designed in the future to protect muscle 
function from inflammation. Especially since the systemic low-level inflammation observed 
in today's metabolic conditions may represent a spillover from local pro-inflammatory 
processes (Bruunsgaard, 2005). 
If skeletal muscle represents the largest organ within the body, then it only makes 
sense to focus on controlling local inflammatory responses within its microvascular bed. 
Molecular therapies are already currently being developed to minimize inflammation, such as 
inhibiting TNF-a in animal trials to combat muscular atrophy (Roth et al., 2006). There are 
also histamine receptor antagonists for both the HI (pyrilamine) and H2 (cimetidine) 
receptors (Van de Voorde et al., 1998). Therefore, understanding the mechanism of action of 
23 
CHAPTER 2: RESEARCH OBJECTIVES 
inflammatory mediators in the microvascular bed of skeletal muscle will lead to methods of 
targeted regulation in the future. 
In summary, the objectives of this study were: 
1) To learn and master microsurgical and intravital microscopic techniques required 
for studying mouse microcirculation. 
2) To assess endothelial and smooth muscle responsiveness within 2A arterioles of 
the mouse gluteus maximus after muscle exteriorization. 
3) To record how inflammatory mediators affect arteriole diameter in the gluteus 
maximus, using histamine and PAF. 
4) To gauge the role of the NO pathway in the gluteus maximus arterioles during 
inflammation, using histamine during pharmacological NO inhibition. 
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Chapter 3: Methodology 
3.1 Animal Care and Surgery 
All procedures were approved by the UNBC Animal Care and Use Committee. Mice 
were purchased from Jackson Laboratories (Bar Harbour, ME) and housed at 22°C over a 12 
hour light/ 12 hour dark cycle with free access to fresh food and water before 
experimentation. Male C57BL6 mice of 8-12 weeks of age between 20-30 g were each 
anesthetized with a ketamine/ xylazine cocktail (1 mg ketamine/ 10 g; 0.1 mg xylazine/10 g) 
via intraperitoneum injection. We developed an anesthetic protocol to monitor the plane of 
anesthesia every 10 minutes. Additional injections were provided as needed to prevent 
withdrawal from toe pinch. 
To prepare mice for surgery, the back was shaved and any excessive hair that could 
interfere with muscle function and visibility was removed. Mice were then laid prone on an 
acrylic stage under a stereomicroscope for excision of the gluteus maximus muscle with 
sterile microsurgical instruments. Body temperature was maintained at 34°C with a heating 
lamp. A Pasteur pipette was used to keep the muscle moist with freshly prepared 
physiological saline solution (PSS) (pH 7.4, 34°C, 131.9 mM NaCl, 4.7 mM KC1, 1.2 mM 
MgS04-7H20, 2.0 mM CaCl2-2H20, and 18.0 mM NaHC03, equilibrated with 5% C02-95% 
N2, as used by Payne et al. (2004). The proximal edge of the muscle was freed from the spine 
by cutting connecting tissue, allowing the muscle to peel away. Careful attention was paid to 
prevent touching the muscle with surgical instruments, as well as to preserve the muscle's 
neurovascular supply and insertion into the femur. Furthermore, inflammatory tissue damage 
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in the central region was minimized by handling only the outer edges of the muscle. The 
freed muscle was pinned down flat over a transparent Sylgard 184 mold (Dow Corning, 
Midland, MI) and the complete apparatus transferred to an intravital microscope for analysis. 
After each experiment was finished, mice were euthanized via anesthesia overdose to the 
intraperitoneum (Payne et ah, 2004). 
One 2A arteriole was examined for each mouse in the central region of the muscle for 
all experiments. No tissues were used for data collection if white blood cells within the 
microvessels or dysfunctional blood flow were detected through the IVM after microsurgery. 
Preliminary microsurgeries were performed (n= 17) before using any vasoactive reagents to 
minimize inflammatory reactions and optimize tissue exteriorization. Once the protocols 
were established, at least five mice were used for each IVM experiment to establish statistical 
significance (n = 13 for Ach experiments, 13 for PE, 13 for histamine, 13 for PAF, 14 for L-
NAME, and 7 for L-NAME/ histamine). Any mice that had adverse reactions to anesthetic or 
PSS wash were not used for data collection. A total of 51 mice were used for this study. 
3.2 Chemicals and Reagents 
All salts used to prepare buffers (NaCl, KC1, CaCl2-2H20, MgS04-7H20, NaHC03) 
were purchased from Fisher Scientific (Ottawa, ON). All reagents were purchased from 
Sigma-Aldrich (St. Louis, MO). This included Acetylcholine chloride (Ach), (R)-(-)-
Phenylephrine hydrochloride (PE), histamine, l-O-Palmityl-sn-glycero-3-phosphocholine 
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(PAF), Nffl-nitro-L-arginine methyl ester hydrochloride (L-NAME), and sodium nitroprusside 
(SNP). 
All reagents used on the muscle in this study were suspended in fresh PSS. Working 
PSS stock was prepared following procedures of Payne et al. (2004) by mixing 20X of Basic 
Salt Buffer (2638 mM NaCl, 94 mM KC1, 23.4 mM MgS04-7H20, 40 mM CaCl2-2H20) 
with 20X of Sodium Bicarbonate Buffer (360 mM). Basic Salt Buffer and Sodium 
Bicarbonate Buffer stocks were stored at 4°C. The tubing of the IVM apparatus was flushed 
with 1% HC1, followed by H20 in a 1:3 volume ratio. 
3.3 Intravital Microscopy 
Water from a hot water bath was circulated through the outer jacket of a glass 
reservoir (Radnoti, Monrovia, CA) so that any fluids contained within the inner jacket would 
flow over the skeletal muscle at 34°C. Fluid volume within the inner jacket was gradually 
restored to 50 mL via gravity through the connection of an elevated 1 L stock bottle of fluid. 
C02/ N2 gas filled the inner jacket at a constant rate to equilibrate the reservoir. PSS was then 
flushed through the system, so that the first drops coming in contact with the muscle would 
approximate physiological conditions. 
All solutions would leave the inner jacket via a gravity controlled valve at 5 mL/ min 
through a drip line secured above the muscle. Thus, fluid gently flowed over the muscle. A 
wick was developed with Kimwipes on the Sylgard mold to gently pull fluid off the muscle 
via capillary action. This allowed a gentle withdrawal of fluid away from the washed muscle 
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and prevented any leakage onto the IVM apparatus (Figure 4). All fluid located around the 
muscle or stored in the glassware was suctioned into a large waste beaker. At the end of each 
experiment, all tubing and glassware was flushed with 1% HC1, followed by water to remove 
any traces of salt precipitates or contaminants within the pumping system. 
Figure 4. Mouse preparation for intravital microscopy recordings. The outer corners of the 
gluteus maximus are pinned down flat onto the Sylgard mold. A drip line is secured to gently 
release PSS across the muscle, which is pulled away with Kimwipes and the connected 
suction line. All of the apparatus resting on the IVM is clear to allow the transfer of light 
through the tissue and visualization through the objective lens. 
Once the surgery was complete, the preparation was immediately transferred to the 
stage of the IVM. The muscle was equilibrated in the PSS wash for 60 minutes to allow any 
minimal inflammation to subside. During this time, the blood flow quality of the vasculature 
was observed, leukocyte presence was monitored, and an arteriole branch was selected for 
later investigation. Second- order (2A) branches of the network were chosen from the central 
region of the muscle, which was untouched during microsurgeries. The intraluminal vessel 
diameter of chosen 2A arterioles was measured with video calipers of a Powerlab device and 
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the corresponding Chart program (ADInstruments, 2008). A photo of the measuring 
technique is shown in Figure 5. 
Figure 5. Measurement of arteriole diameter. A 2A arteriole with continuous blood flow in 
the central region of the gluteus maximus was chosen (900X). Video calipers are wired into a 
Powerlab measuring device and video screen. The video camera attached to the IVM is 
rotated to align each vessel with the video calipers (white lines) and the dials are manipulated 
until the lines are on the edge of the arteriole. The corresponding diameter change is routed 
through the Powerlab device into the Chart program to record measurements. The same 
region of the arteriole is measured for the duration of the experiment to minimize variability. 
3.4 Arteriolar Reactivity 
Resting internal diameter was measured in the chosen 2A arterioles after a PSS wash 
to provide a baseline for any changes in vessel size. All diameter changes were calculated as 
the percent difference = (measured diameter- PSS base diameter/ measured diameter) x 100. 
Vascular diameter changes were expressed as percent differences. The same segment of the 
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same 2A arteriole in each mouse was used for the duration of each experiment to reduce 
variation in results. 
The maximal diameter was taken at the end of each experiment by pipette application 
of 1 mM of sodium nitroprusside (SNP) to the muscle. This NO donor directly relaxes 
arteriolar smooth muscle, thus allowing measurement of maximal diameter through 
vasodilatation (Brooks et al., 2008). Thus, baseline and maximal diameters provide an index 
of vasomotor tone during each experiment (Bearden, 2007). Also, having a tone value will 
describe the arteriole's reactivity when exposed to each reagent. Vasomotor tone = (Maximal 
inner diameter - initial baseline inner diameter before the first addition of a pharmacological 
reagent/ maximal inner diameter) x 100. Only the data collected on arterioles that displayed 
vascular tone greater than 20% (Donato et al, 2007) was kept for further analysis. All data 
are reported as means ± standard error. 
3.5 Vasomotor Activity within the Arterioles 
Endothelial and smooth muscle cell function was analyzed in the gluteus maximus 
through cumulative addition of Ach and PE, respectively. For both reagents, a concentration 
range of 1 nM to 100 uM was used. For each concentration, the reagent was pumped over the 
muscle at 5 mL/ min for 2 min and the luminal edges were measured. However, to minimize 
animal use and maintain consistency, the order in which Ach and PE were applied was 
repeatedly alternated. In half the experiments, responses to Ach were washed for 30 minutes 
with PSS before next evaluating the response to PE and vice versa. This method is possible 
30 
CHAPTER 3: METHODOLOGY 
because the activity of both of these agents is reversible after a wash with PSS (Bearden et 
al, 2004). 
3.6 Characterizing Inflammatory Profiles 
After the gluteus maximus was washed with PSS for at least 60 minutes, an 
inflammatory mediator was added to the PSS stock. For each concentration, the 
inflammatory mediator was pumped over the muscle at 5 mL/min for 2 min. After each 
diameter measurement, a higher concentration was immediately administered in a cumulative 
manner. Histamine addition to the PSS superfusion solution ranged from 1 nM to 100 uM. A 
larger range was chosen for PAF (100 fM to 10 uM) to observe where minor diameter 
changes began. 
3.7 The Role of NO in the Locomotion Arterioles 
To evaluate the role of the NO pathway within the 2A arterioles, L-NAME (100 uM) 
was pumped over the muscle after a 60 minute PSS wash. This inhibitor creates a 
pharmacological blockade of all three NOS isozymes (Kumer et al, 2000). Time-dependent 
changes in diameter were measured at 15 minute intervals for 60 minutes. The effect of this 
nitric oxide synthase inhibitor on the arteriolar integrity was also measured during an 
inflammatory state using histamine. After 30 minutes of incubation with L-NAME, a 
histamine dose response curve was constructed in the presence of L-NAME. Finally, 
diameter changes from the inflammatory state and the NO inhibited inflammatory state were 
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statistically compared using a one-tailed independent Student's t-test, where differences were 
qualified as significant if p < 0.05. 
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Chapter 4: Results 
4.1 Gluteus Maximus 2A Endothelial Response to Vasodilator Application 
Vasodilation was successfully initiated within the gluteus maximus arterioles with 
Ach. The vasodilatory range of the gluteus maximus 2A arterioles is illustrated in Figure 6. 
Arteriole diameter increased with an increase in acetylcholine concentration. There was a 
large increase in diameter (63.90%) when doses reached 10 uM. The minimum percent 
difference induced by Ach was 2.92% (1 nM), whereas the maximum percent difference was 
89.18% (100 uM). The average vascular tone among these experiments was 46.92 ±2.88%. 
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Figure 6. Acetylcholine dose response curve. The mean change in diameter (±SE) of the 2A 
arteriole is shown for each treatment concentration (n = 5). All diameter changes were based 
off of baseline PSS wash values. Concentration was increased cumulatively by direct 
application to the visceral layer of the gluteus maximus. 
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4.2 Gluteus Maximus 2A Smooth Muscle Response to Vasoconstrictor Application 
Vasoconstriction was successfully initiated within the gluteus maximus arterioles 
with PE. The vasoconstrictive range of the gluteus maximus 2A arterioles in response to PE 
is illustrated in Figure 7. The arteriole diameter decreased steadily as PE concentration 
increased. The arteriolar diameter began to level off as the dose response curve reached 100 
uM. The minimum percent difference induced by PE was -4.38% (1 nM), whereas the 
maximum percent difference was -58.03% (100 uM). The average vascular tone across these 
experiments was 20.45 ±9.43%. 
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Figure 7. Phenylephrine dose response curve. The mean change in diameter (±SE) of the 2A 
arteriole is shown for each treatment concentration (n = 5). All diameter changes were based 
off of baseline PSS wash values. Concentration was increased cumulatively by direct 
application to the visceral layer of the gluteus maximus. 
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4.3 Gluteus Maximus 2A Arteriolar Response to Histamine Application 
Inflammation was induced in the 2A arteriole using histamine in a dose-dependent 
manner. The arteriole reaction to histamine-induced inflammation is shown in Figure 8. 
Histamine was shown to induce both vasodilation and vasoconstriction in these microvessels. 
The arterioles dilated progressively as histamine concentration rose from 1 nM to 100 nM. 
Then the vessel diameter gradually constricted from 1 uM to 100 uM. The highest amount of 
observed vasodilation was at 0.1 uM (+10.43%), whereas the largest amount of 
vasoconstriction was at 100 uM (-26.34%). The average vasomotor tone across these 
experiments was 54.25 ±5.51%. It is also important to note that blood flow became sluggish 
during histamine application. 
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Figure 8. Histamine dose response curve. The mean change in diameter (±SE) of the 2A 
arteriole is shown for each treatment concentration (n = 5). All diameter changes were based 
off of baseline PSS wash values. Concentration was increased cumulatively by direct 
application to the visceral layer of the gluteus maximus. 
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4.4 Gluteus Maximus 2A Arteriolar Response to PAF Application 
Inflammation was also induced in the 2A arteriole using PAF in a dose-dependent 
manner. The arteriole reaction to PAF induced inflammation is shown in Figure 9. Arterioles 
constricted steadily as the concentration of PAF increased from 100 fM to 10 uM. The 
minimum percent difference induced by PAF was -10.22% (100 fM) and the maximum 
difference was -32.73% (10 uM). Vasoconstriction began to peak at 10 uM. The average 
vasomotor tone across these experiments was 36.84 ±2.93%. Blood flow also became 
sluggish within the arterioles after PAF application. 
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Figure 9. Platelet Activating Factor dose response curve. The mean change in diameter (±SE) 
of the 2A arteriole is shown for each treatment concentration (n = 5). All diameter changes 
were based off of baseline PSS wash values. Concentration was increased cumulatively by 
direct application to the visceral layer of the gluteus maximus. 
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4.5 Gluteus Maximus 2A Arteriolar Response to L-NAME Application 
The activity of nitric oxide synthases was blocked in the 2A arterioles over time using 
L-NAME. The gradual inhibition of NO production is illustrated in an L-NAME time curve 
(Figure 10). Arteriole diameter decreased steadily over time as L-NAME flowed over the 
muscle. Vasoconstriction began to level off at 60 minutes of equilibrium (-21.28%). The 
average vascular tone of arterioles exposed to L-NAME was 25.63 ±3.41% and there was 
little reactivity to the application of SNP. 
Figure 10. L-NAME time response curve. The mean change in diameter (±SE) of the 2A 
arteriole is shown for each time interval (n = 5). All diameter changes were based off of 
baseline PSS wash values. The gluteus maximus was continuously equilibrated in 100 uM of 
L-NAME over the course of the experiment. 
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4.6 Gluteus Maximus 2A Arteriolar Response to Histamine in the Presence of L-NAME 
After a 30 min wash of the 2A arteriole with 100 uM L-NAME, inflammation was 
induced with histamine/ L-NAME solution in a dose-dependent manner. The effect of 
inhibiting histamine mediated inflammation via the NO pathway is shown in Figure 11. The 
average vasomotor tone of histamine/ L-NAME treated arterioles was 20.02 ±6.67%. In the 
presence of L-NAME, histamine maintains its arteriolar effect, shifting from vasodilation to 
vasoconstriction with increasing concentration. Increases in diameter peaked (-6.88%) with 
100 nM of histamine. As with histamine alone, arterioles immersed in 100 uM L-NAME 
began vasoconstricting as histamine concentration rose from 1 uM to 100 uM. 
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Figure 11. The effect of histamine during inhibition of NO production. Histamine 
concentrations were diluted in 100 uM L-NAME in a cumulative dose response. The mean 
change in diameter (±SE) for each concentration were calculated for n = 5. Percent 
differences were based off of baseline PSS wash values. Concentration of histamine was 
increased cumulatively by direct application to the visceral layer of the gluteus maximus. 
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Arterioles were shown to behave differently towards histamine before and after NO 
inhibition. A comparison of both histamine dose response curves is shown in Figure 11. The 
presence of L-NAME attenuated the impact of histamine on arteriole diameter. However, 
vasodilation was found to be significantly different before and after NO inhibition. The 
maximal vasodilation reached by histamine/ L-NAME and histamine/ PSS was at 100 nM. In 
addition, both histamine solutions reached similar vasoconstriction values at 100 uM. 
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Figure 12. The effect of histamine on 2A arteriole size before and after inhibition of NO 
production. The mean change in diameter (±SE) of the 2A arteriole is shown for each 
treatment concentration (n = 5). All diameter changes were based off of baseline PSS wash 
values. For each inflammatory condition, concentration was increased cumulatively by direct 
application to the visceral layer of the gluteus maximus. Significant differences between PSS 
and L-NAME for each concentration are noted with an asterisk. 
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Chapter 5: Discussion 
5.1 Validation of IVM Techniques and Tissue Integrity 
This study determined the arteriole reactivity of 2A arterioles in the mouse gluteus 
maximus under both physiological and pathological conditions. The acetylcholine (Ach) and 
phenylephrine (PE) dose response curves (Figures 6 and 7, respectively) illustrate the 
presence of both endothelial and smooth muscle activity. If there was any surgical damage, 
attenuated and inconsistent responses would have been observed. Endothelial damage has 
been shown to abolish responses to Ach, while smooth muscle damage inhibits responses to 
PE (Bartlett & Segal, 2000). 
The maintained arteriole reactivity in both cell layers that we observed indicates that 
the integrity of each layer remained in tact within the gluteus maximus. If the integrity and 
functionality of both endothelial and smooth muscle layers are maintained, proper cell 
communication can also proceed through myoendothelial junctions (Griffith, 2004). 
Furthermore, a healthy vascular tone persisted when we used these reagents. Donato et al. 
(2007) discarded any arterioles that had a vascular tone of less than 20%, but all arterioles 
used in our study displayed a tone of 20% or greater. Therefore, the 2A arterioles observed 
were appropriate for microvascular study. 
Coagulated blood was another hazard to avoid for preventing damaged 
microcirculation within the gluteus maximus. This disruption in blood flow was observed in 
preliminary experiments, but was absent after surgical practice. The lack of coagulation 
before data collection correlates to a lack of inflammation since these two pathways have 
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been shown to be linked, with the activation of one subsequently activating the other (Cinel 
& Opal, 2009). For example, LPS-induced endotoxemia accelerated microvascular thrombus 
formation in cremaster muscles of mice (Lindenblatt et ah, 2006). Impaired RBC velocity 
was also found in capillaries of rat extensor digitorum longus muscle once sepsis was 
induced (Tyml et ah, 1998), so sluggish blood flow could be a marker for inflammation. 
Furthermore, sluggish blood flow was observed in both histamine and PAF exposed 
arterioles. Therefore, observing a continuous blood flow through the IVM indirectly 
indicated a lack of inflammation within the arterioles. 
The gluteus maximus could successfully be excised using microsurgical techniques 
without inducing acute inflammation within the area of interest. During acute inflammation, 
injury or damage causes an accumulation of interstitial fluid and white blood cells throughout 
the microcirculation (Bucci et ah, 2005). For example, soft tissue trauma caused increased 
leukocyte-endothelial cell interactions and a significant reduction in capillary perfusion in rat 
skeletal muscle tissue (Gierer et ah, 2008). In our study, no circulating white blood cells 
were observed though the IVM during data collection. Therefore, careful handling of only 
the outer edges of the gluteus maximus during microsurgies prevented damage to the central 
region, preserving the microcirculation. 
Preventing the release of inflammatory mediators within the central region of the 
gluteus maximus is important to prevent any inflammatory interactions. For instance, 
inflammatory priming or synergistic effects have been observed in the microcirculation (Noel 
et ah, 1995), so induction of severe trauma in the tissue could create a completely different 
inflammatory environment for future measurements. The healthy microcirculation observed 
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in the 2A arterioles supports the use of surgical and physiological techniques used during 
intravital microscopy. However, for further confirmation molecular analysis could be 
employed, such as performing inflammatory mediator specific western blots of muscle 
biopsies and/ or isolated arterioles (Starkie et ah, 2003). These could be performed at the end 
of each IVM experiment to build a molecular profile to match to the arteriole vasomotor 
tone. By complementing the physiological with the molecular aspects of arteriole function, 
more inflammatory quantification will be obtained. 
5.2 Vasoactivity of the Gluteus Maximus 2A Arterioles 
Vasodilation and vasoconstriction was induced in the gluteus maximus 2A arterioles 
using Ach and PE, respectively. Arteriole responsiveness to the cumulative addition of both 
Ach and PE began leveling off at 100 uM. This vasoactive behavior also agrees with the 
gluteus maximus vasoactivity seen by Bearden et al. (2004) when using Ach and PE. 
Therefore, a vasoactive spectrum is now confirmed for arterioles within the mouse gluteus 
maximus. Furthermore, these experiments provide the maximum and minimum dosages 
required to induce a vasoactive change in the 2A arterioles of the gluteus maximus. 
A greater change in arteriole diameter was induced with Ach than with PE. This 
response can be explained through the mechanism of action of the two vasoactive reagents. 
Ach induced vasodilation is endothelium-dependent, whereas PE acts directly on the vascular 
smooth muscle to induce vasoconstriction (Tran & Welsh, 2009). Since Ach's vasoactive 
signals can travel from the endothelium to the smooth muscle layer via secondary 
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messengers (Matoba & Shimokawa, 2003), the vasodilator essentially recruits two different 
cell types to invoke a response. The ability to utilize the endothelium and cause greater signal 
transmission along the arteriole wall makes Ach a good reagent to use for measuring cell 
communication (Diep et al., 2005). The induced dilation may be mediated through the NO 
pathway, but Ach was found to cause vasodilation despite inhibition of NOS (Fitzgerald et 
ah, 2007). Other secondary messengers, such as EDHF or PGI2, can compensate for a lack of 
NO in the arteriole. The variety of vasodilatory alternatives may contribute to Ach's ability 
to induce a greater response than PE. In our study, the arterioles used for Ach displayed 
higher vasomotor tone than PE, which is an important precursor for cell communication 
(Donato et al., 2007). Thus, the effects of this vasoactive reagent will be enhanced by 
preparing arterioles with higher reactivity. 
In the present study, the two vasoactive reagents were applied directly to the muscle 
to stimulate the global arteriole network. Future studies can select the appropriate dose for 
inducing a CVD with local concentrations derived from this reactivity range. For instance, a 
physiological dose of Ach can be delivered with a micropipette to initiate CVD in the gluteus 
maximus for these mice (Bearden et al., 2004). Initiating CVD will allow cell 
communication to be quantified at different sites along the 2A branches of the arteriolar tree. 
The physiological concentration obtained is also useful so that arterioles can regain their 
original diameter if multiple doses are administered to skeletal muscle (Payne et al, 2004). 
The physiological baseline obtained for each cell layer can also be compared with 
pathological processes, such as the dilator response to Ach in Cx40 knockout mice (de Wit et 
ah, 2000). The impact of any genetic knockouts related to cell communication may now be 
compared with the physiological reactions of this study. Both physiological and pathological 
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conditions can now be derived from our vasoactive range to invoke new responses within the 
gluteus maximus. 
5.3 The Impact of Inflammatory Mediators on Gluteus Maximus 2A Arterioles 
This was the first study to our knowledge that induced inflammation in the 2A 
arterioles of the mouse gluteus maximus. Histamine displayed both vasodilator and 
vasoconstrictor properties in the 2A arterioles of the gluteus maximus (Figure 8). The 
mechanism of action for histamine is based on its concentration. Obtaining an inflammatory 
dose response curve is essential because histamine is vascular bed specific (Payne, 2006). 
Consequently, this mediator has the potential to behave differently within each of the body's 
tissues. Histamine can cause vasoconstriction, vasodilation, or a combination of these 
responses, depending on the dose, route of administration, animal species, anatomic region, 
caliber and pre-existing tone of the vessel (Van de Voorde et ah, 1998). We have illustrated 
some of the arteriolar effects of this specific inflammatory mediator. 
Interestingly, histamine displayed a similar arteriolar effect within the gluteus 
maximus as other mouse skeletal muscle. The histamine dose response curve used by Payne 
et al. (2003) for the mouse cremaster was found to peak in arteriole vasodilation at 1 uM 
before constricting. In both skeletal muscles the arteriole reaches a vasodilatory peak, 
followed by gradual vasoconstriction. These similar diameter changes illustrate that even 
though histamine has the potential to vasodilate and/ or vasoconstrict in a multitude of ways 
between tissues (Van de Voorde et ah, 1998), that there can be similar effects within skeletal 
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muscle tissues. However, there can still be subtle differences. There was less of a change in 
diameter observed in the gluteus maximus of this study than that seen by Payne et al. (2004) 
when the cremaster was used. The regular locomotion utilized by the gluteus maximus may 
provide protective effects against inflammatory attacks, as physical activity has anti-
inflammatory effects (Pedersen & Fischer, 2007). The large diversity of physiology observed 
in tissue types, vascular beds, and branching order warrants further exploration of the 
microcirculation. Our study shows that even differences in tissue functionality/ muscle fiber 
composition can create minor differences in the microvascular response to inflammation. 
Having the information on how each mediator will behave at a specific concentration 
is useful for when its arteriolar effect is not uniform. Both vasodilation and vasoconstriction 
were observed with varying dosages of histamine in our study, as well as by Payne et al. 
(2003). Dosages can also be linked to other physiological processes besides arteriolar size, 
such as cellular behaviour. For example, Asako et al. (1994) found that only a certain dosage 
of histamine caused recruitment of rolling leukocytes to rat mesenteric venules. Although no 
video recordings were made in this study, analyzing video footage of fluorescently labeled 
leukocytes could allow correlations to be made between the diameter and cellular effects of 
each inflammatory mediator on the gluteus maximus arterioles (Gavins & Chatterjee, 2004). 
In addition, intlammatory mediators may also induce different effects between branches of 
the arteriolar network. For example, when TNF-a was applied to rat cremaster tissue, only 
the third and fourth order arterioles were dilated significantly as a continuous phenomenon 
after three hours (Adanali et al., 2001). Thus, the complete arteriolar network of the gluteus 
maximus may be examined with PAF and histamine to build a response profile. 
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This study demonstrated vasoactive differences between inflammatory mediators in 
the gluteus maximus. Unlike histamine, PAF plays a strictly vasoconstrictor role within the 
vascular bed of the gluteus maximus (Figure 9). Arteriolar vasoconstriction was also 
observed in the hamster cheek pouch by Kim et al. (2000). It is possible that PAF may not be 
as tissue dependent as histamine. When comparing the vasoconstrictive impact between these 
two mediators in the gluteus maximus, PAF was found to exert a greater effect than 
histamine. Whereas a 100 ^M dilution of histamine induced a 26.34% decrease in arteriole 
diameter, a greater decrease (28.00%) was caused with a 10 uM dilution of PAF. If PAF 
produces such a prevailing vasoconstrictive environment, it could be more difficult for the 
CVD to travel along skeletal muscle arterioles, leading to hypertension (de Wit et al., 2000). 
However, this is the first study to use PAF mediated inflammation in the gluteus maximus, so 
further work must be performed to probe into its mechanism of action. 
Obtaining the inflammatory range for each mediator is beneficial because individual 
concentrations can be selected to simulate specific inflammatory conditions in skeletal 
muscle. For example, a high concentration may be used to induce severe acute inflammation, 
a medium concentration for an acute physiological response, or a low concentration for a 
low-grade inflammatory state. Techniques that elicit chronic low-grade inflammation have 
recently been developed using slow-release endotoxin pellets. Implanting these pellets 
beneath the skin enables controlled inflammatory dosing over extended periods of time with 
limited animal handling and stress (Smith et ah, 2009). This method is modeled after the 
acute inflammation induced in mice for septic studies (Gocan et al., 2000). Physiological 
concentrations of histamine have also been used to create a reversible state of inflammation 
with the mouse cremaster (Payne et al, 2004). Thus, having inflammatory profiles for both 
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histamine and PAF can allow a spectrum of inflammatory responses to be researched in 
mice. 
5.4 The Role of NO During a Physiological and Inflammatory State 
Vasoconstriction escalated with time in the 2A arterioles as L-NAME washed over 
the gluteus maximus. All NOS isozymes are competitively inhibited by L-NAME, so over 
time it will increasingly fill more active sites until the NO supply to the arterioles becomes 
severely depleted (Kumer et al, 2000). Our results indicate that the NO pathway plays a key 
role in maintaining arteriolar diameter within the gluteus maximus. Murphy et al. (2007) also 
found that washing rat cremaster muscles with 100 uM of L-NAME induced arteriolar 
constriction. The predominant vasoconstriction seen in skeletal tissue after an NO blockade 
will reduce the amount of vasodilator signals being sent along the arteriole (Kumer et al, 
2000). Also, the sluggish blood flow observed may be a result of increased RBC coagulation 
from a lack of NO regulation (Crimi et al, 2007). Therefore, NO is an essential secondary 
messenger to maintain the health of skeletal muscle microcirculation. 
As noted by Sundrani et al. (2000), L-NAME's ability to induce vasoconstriction 
could be therapeutically useful if chronic inflammatory states were causing prevalent 
hypotension. Overproduction of NO can lead to a dramatic decrease in RBC deformability, 
which can lead to random blockage of the microvascular beds and reduce blood flow 
(Bateman et al, 2001). However, caution must also be taken to not completely deplete NO 
levels required for maintaining arteriole health. When a nonselective nitric oxide synthase 
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inhibitor treatment regimen was used on patients suffering from septic shock, mortality 
actually increased (Lopez et al, 2004). Thus, a NO deficiency is just as threatening to the 
tissues as a NO surplus in the vasculature. 
A selective NO blockade will also alter blood flow regulation within the skeletal 
muscle. Blocking eNOS as well as calcium-activated potassium channels in mouse cremaster 
arterioles has been shown to inhibit the CVD (Figueroa et al, 2007). It was found that eNOS 
(7) mice have a defective post-contraction hyperemic response due to limb ischemia, which 
can be reversed with local delivery of an adenovirus containing an active form of eNOS (Yu 
et ah, 2005). The ability to restore blood flow in these knockouts provides further evidence 
that the NO pathway is essential to intercellular communication within the arteriole. 
Furthermore, selectively inhibiting iNOS after the induction of sepsis actually increased 
capillary RBC velocity and local oxygen consumption in rat skeletal muscle (Bateman et al., 
2008). Thus, NO is a key secondary messenger to regulate in the skeletal muscle 
microcirculation. 
Interestingly, histamine-induced vasodilation was attenuated in the presence of L-
NAME, when compared to the effect of histamine alone. However, vasoconstriction 
proceeded similarly under both conditions. The attenuated arteriolar response to histamine in 
the presence of L-NAME illustrates that NO is a key requirement for an inflammatory impact 
on the arteriole network. The ability of histamine to spread vasodilatory signals between cells 
of the arteriole was attenuated without the presence of NO. Therefore, this study identified a 
key inflammatory mechanism within the arteriolar network of a locomotory muscle. 
Pharmacological blockade of NO production also attenuated the effect of histamine on the 
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CVD in arterioles (Payne et al, 2004). Treatment of the rat mesentery venules with L-
NAME lead to increased vascular leakage and altered endothelial cytoskeleton (Baldwin et 
ah, 1998). The inhibition of NO could therefore be affecting the arteriolar integrity by 
loosening the cytoskeleton and attenuating cell communication. 
In this study, histamine was chosen to investigate the role of the NO pathway during 
inflammation. However, it is still possible that PAF is affected by NO levels. When PAF 
binds to its receptor, it activates a pathway which generates the secondary messengers 
diacylglycerol and inositol 1,4,5-triphosphate (IP3) (Liu & Xia, 2006). Since these 
messengers both signal Ca2+ release within the endothelium, the NO pathway can still be 
activated indirectly. Production of NO by PAF was found in rat venular mesenteries, which 
could be inhibited by NOS inhibitor L-NMMA (Zhu & He, 2005). In the future, the 
relationship of the NO pathway to PAF function in the gluteus maximus 2A arterioles could 
be tested with the use of a pharmacological blockade, as in this study, or through NOS 
isozyme gene knockout mice, as used by Payne et al. (2004) for histamine. 
Although numerous mice were required to perform these experiments, we have now 
gained a better understanding of skeletal muscle microcirculation. Extensive physiological 
and pathological details simply cannot be obtained without animal models, as existing 
technology for direct visualization of arteriole function is currently lacking for human 
subjects (Gavins & Chatterjee, 2004; Sakr et al, 2004). Not only was arteriole function 
broken down into endothelial and smooth muscle components within the arteriole, but also 
arteriolar changes were recorded for two of the most potent mediators of inflammation (Chen 
et al., 2008; Payne et al., 2004). Furthermore, all this information was collected in a 
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locomotory muscle, so more microvascular research may now use our findings to probe into 
the links between inflammation and skeletal muscle arteriole dysfunction. Cardiovascular 
disease is currently the leading cause of mortality for both men and women in Canada and 
becomes more prevalent with our aging population (Public Health Agency of Canada, 2008). 
Any insights into how inflammation disrupts the skeletal muscle microcirculation will lead to 
methods of preservation for the muscle and greater potential for increased blood flow 
throughout the cardiovascular tree. 
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Chapter 6: Research Implications and Future Directions 
6.1 Regulating Inflammation 
This study illustrates how inflammation can be attenuated within skeletal muscle 
microcirculation, but these regulatory techniques can also be applied to other cardiovascular 
conditions, such as diabetes and hypertension. For instance, decreased muscle mass has been 
found in aging individuals with type 2 diabetes (Pedersen et ah, 2003). Furthermore, diabetic 
patients with microvascular complications had longer duration of diabetes and worse 
glycemic control than diabetic patients without complications (Brooks et al., 2008). In 
addition, weakened vasodilation was found in the skeletal muscle of hypertensive animal 
models through reduced expression of Cx43 (Kurjiaka et ah, 2005). A slower spread of 
vasodilation in skeletal muscle arterioles and higher blood pressure was also seen in Cx40 
deficient mice (de Wit et al, 2000). 
More treatment methods may be used for these conditions once the underlying 
mechanisms become known. For example, using L-NAME mediated chronic NOS inhibition 
over four weeks in diabetic mice enhanced the contribution of EDHF, providing an 
alternative for endothelium-dependent relaxation in isolated mesenteric arteries (Fitzgerald et 
al, 2007). Since inflammation is present in the vasculature of subjects with both diabetes and 
hypertension (Brooks et al, 2008; Erdei et al, 2006), finding other ways to reverse the 
effects of inflammation will increase the health of the cardiovascular system. Maintaining 
blood flow regulation will thus prevent/ protect skeletal muscle from the development of 
debilitating chronic conditions. 
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Regulatory techniques must be designed to minimize the impact of inflammation on 
the cardiovascular system. However, regulating inflammatory mediators is a challenge 
because they are generated and released from numerous cell types, such as platelets, mast 
cells, monocytes, or macrophages (Weis, 2008). For example, PAF alone can be produced by 
monocytes/ macrophages, polymorphonuclear leukocytes, eosinophils, basophils, platelets, 
mast cells, endothelial cells, and lymphocytes (Liu & Xia, 2006). Each mediator also has the 
potential to activate other inflammatory cascades. PAF is potent enough to not only induce 
inflammation, but also mediate synthesis and release of other mediators to aggravate the 
degree of inflammation (Chen et ah, 2008). The difficulty in controlling one mediator among 
numerous inflammatory cascades and cellular sources makes finding an overlapping 
mechanism of action crucial. 
Further complicating matters is the reality that inflammation can have beneficial or 
detrimental effects, depending on the context. For instance, TNF-a is secreted predominantly 
by monocytes and macrophages and has wide ranging biological effects on lipid metabolism, 
coagulation and endothelial function (de Luca & Olefsky, 2008). Moreover, a different 
subset of monocytes may be recruited during acute inflammation than that utilized for 
chronic diseases (Arnold et al., 2007). Therefore, regulating inflammation can have other 
vascular consequences. The combination of diverse capabilities with a large resource pool 
provides inflammatory mediators with a powerful influence over the microcirculation, 
creating a challenge for regulation. 
It is implausible to reduce inflammation by targeting all the different cells and 
mediators for regulation. However, if the most influential mediators can be found, targeted 
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interventions could be used. PAF antagonists have already been designed to reduce the 
impact of acute pancreatitis (Liu & Xia, 2006). Mice strains with genetic knockouts of TNF-
a have already been used to study the cremaster post-capillary venules during inflammation 
(Norman et ah, 2005). Also, if a common mode of action on the microcirculation is found for 
a collection of mediators, future therapies will become more successful. For instance, if the 
NO pathway is being used for inflammatory action, NO regulation techniques may be used. 
This could include chronic inhibition of NO with minimal levels of a non-selective inhibitor 
(Fitzgerald et al., 2007) or targeting specific isozymes with inhibitors during their time of 
maximal activity (Lidington et al., 2007). 
This study found different modes of action in the arteriole for two inflammatory 
mediators. Expanding the methods we used for application to other inflammatory mediators 
may lead to a further understanding of the inflammatory process. Our study is the first 
attempt at arteriolar inflammation in the gluteus maximus in mice and is a crucial new 
avenue to explore, since the majority of animal research has focused on the cremaster as the 
major tissue to describe skeletal muscle microcirculation. Eventually, inflammatory 
interactions may be observed within the arteriole. For example, primed and synergistic 
effects between histamine and PAF have already been investigated within hamster cheek 
pouch venules (Noel et al., 1995; Tomeo et al., 1991). Knowing the separate actions of these 
mediators will thus allow a comparison between the individual mediators, so that they may 
be compared with combinatorial effects. 
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6.2 Aging 
The responsiveness of arterioles towards vasoactive reagents has been shown to 
change as skeletal muscle becomes older. For instance, aging is associated with a greater a-
adrenergic vasoconstriction in arterioles from high oxidative soleus skeletal muscle in rats 
(Donato et al., 2007). The reduced capacity of arterioles (as well as conduit arteries) to dilate 
may contribute to a reduction in muscle blood flow and ultimately limit the ability of older 
adults to perform functional tasks (Payne, 2006; Taddei et ah, 2001). The significant 
inflammatory biomarkers associated with poor physical performance in the elderly are 
already being sought out (Hsu et al, 2009). For example, NO bioavailability is lower in the 
circulation of aging subjects (Taddei et al, 2001). Similar CVD profiles were also found in 
the mouse cremaster when comparing aged and histamine-exposed, adult mice (Payne et al, 
2004). Therefore, certain mediators may cause similar microvascular deficits between 
different age groups in both large and small vessels. In our study, the function of the 2A 
arterioles was measured in adult mice. However, the arteriolar network architecture in the 
gluteus maximus appears to be maintained during aging (Bearden et al, 2004). Thus, the 2A 
arterioles of adult mice could be compared with older mice to observe how vasomotor and 
inflammatory functionality differs between these similar structures. 
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6.3 Gender Differences 
Being able to successfully perform microcirculatory measurements on the gluteus 
maximus proves that this is a prospective new tissue to be used in skeletal muscle studies of 
mice. Unlike the cremaster muscle, the gluteus maximus allows gender comparisons to be 
made. Gender differences have already been seen in the macrocirculation. Unlike women, 
men were shown to have similar leg hemodynamic responses between young and older age 
groups after an exercise regimen (Parker et al., 2008). Furthermore, the femoral artery dilated 
to a greater extent after dynamic leg exercise in young women vs. men (Parker et ah, 2007). 
A slower rate of vasodilation in gluteus maximus 2A arterioles has already been observed in 
male mice when compared to females (Bearden, 2007), suggesting similar vasomotive 
reactions in the microcirculation. The greater function of circulation in the skeletal muscle of 
females needs further clarification. There was enhanced NO mediated endothelium-
dependent relaxation in female rat mesenteric arterioles when compared to males (White et 
ah, 2000). This greater NO utilization could also extend to the skeletal muscle, which could 
be tested out using the L-NAME as in our study. 
6.4 Physical Activity 
Another major benefit of being able to observe the microcirculation in the gluteus 
maximus is that the impacts of physical activity can be researched. Physical activity is known 
to not only increase blood flow during skeletal muscle contraction (Armstrong et ah, 2007b) 
and after endurance training sessions (McAllister et al, 2008), but also to increase 
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microvascular density (Laughlin et al, 2006). However, anti-inflammatory effects can also 
be investigated, such as identifying the myokines that are released from skeletal muscle 
during exercise (Pedersen & Fischer, 2007). Skeletal muscle is now being examined as an 
endocrine organ to find what pathways connect physical activity to cardiovascular health. 
Even three hours of exercise weakened the effect of low-grade inflammation. When 
this exercise regimen was followed in humans before endotoxin injection, any induced 
increases in TNF-a were attenuated (Starkie et al, 2003). Furthermore, assigning aging 
individuals to both endurance and resistance training reduced the expression of active 
monocytes circulating in the blood (Timmerman et al, 2008). Physical activity must 
somehow mediate anti-inflammatory pathways. This may also explain why a locomotory 
muscle would be more resistant to the effects of histamine when compared to a non-
locomotory muscle. It is quite possible that there are higher levels of anti-inflammatory 
myokines circulating throughout the microcirculation of the gluteus maximus. This may 
create an anti-inflammatory potential for protection against inflammatory attacks. 
Some mechanisms of activity-mediated increases in physical activity have been 
investigated. For instance, it is possible that the activity of the NOS isozymes becomes 
physiologically altered with physical activity. Chronic exercise in dogs caused an increase in 
eNOS expression of the microcirculation (Sessa et al., 1994). Thus, exercise may shift NO 
production towards levels healthier for the arteriole beds supplying the active muscle. In 
addition, exercise training was shown to prevent hypoxia-induced increases in leukocyte-
endothelial adherence and in vascular permeability in the cremaster muscle of rats (Orth et 
ah, 2005). This impact even persisted for another month after training was discontinued. 
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However, the cremaster is not a locomotor muscle, so testing the effects on other muscles to 
see direct rather than secondary effects may provide insights into what exercise regimen is 
most beneficial for microvascular health. Future studies could include using an exercise 
regime for mice, as either a preventative or intervention method for inflammation, to further 
clarify the microvascular effect of exercise on the gluteus maximus. 
Conclusion 
In this study, we performed numerous experiments on the mouse gluteus maximus. 
The use of intravital microscopic techniques to study inflammation in this muscle proved 
useful in studying vasoreactivity within the arteriole network. Furthermore, inflammatory 
profiles for 2A arteriole diameter changes were obtained for histamine and PAF. The 
vasoconstriction obtained after nonspecific nitric oxide synthase inhibition was also seen to 
attenuate the impact of histamine-mediated inflammation. Therefore, this study provided the 
foundational data for inflammatory studies within the gluteus maximus and suggests that this 
skeletal muscle can be used to study deficits of blood flow regulation. Future work may now 
expand on the current results to study how inflammatory regulation, aging, gender diffences, 
and physical activity impact the skeletal muscle arteriole network. 
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